Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ)
CNY 18.76
(-0.11%)
CNY 18.76
(-0.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.93 Million | 89.38 Million | 35.96 Million | 106.28 Million | 29.03 Million | 37.32 Million |
| Net Income | 18.44 Million | 79.68 Million | 63.52 Million | 48.38 Million | 34.4 Million | 48.21 Million |
| Depreciation & Amortization | 11.18 Million | 13.32 Million | 8.22 Million | 8.31 Million | 7.59 Million | 2.78 Million |
| Deferred income taxes | 6.3 Million | -3.76 Million | 782.54 Thousand | 29.11 Thousand | -37.72 Thousand | -41.68 Thousand |
| Stock-based compensation | -1.87 Million | 10.96 Million | - | - | - | - |
| Change in working capital | -21.68 Million | -14.34 Million | -33.89 Million | 51.31 Million | -13.61 Million | -15.01 Million |
| Other non-cash items | -2.47 Million | 10.71 Million | -1.89 Million | -1.73 Million | 651.21 Thousand | 1.33 Million |
| Investing Cash Flow | -172.34 Million | -164.36 Million | -169.37 Million | 32.3 Million | -31.87 Million | -45.93 Million |
| Investments in PPE | -176.24 Million | -29.14 Million | -25.91 Million | -7.07 Million | -22.37 Million | -42.29 Million |
| Acquisitions | 180.29 Thousand | 143.81 Thousand | 77.23 Thousand | 68.85 Thousand | 7300.00 | 32 Thousand |
| Investment purchases | -4 Million | -420 Million | -504 Million | -475.8 Million | -188 Million | -220 Million |
| Sales/Maturities of investments | 397.71 Million | 284.63 Million | 356 Million | 510.8 Million | 178 Million | 215 Million |
| Other Investing Activities | 7.71 Million | 0.81 | 4.46 Million | 4.31 Million | 486.48 Thousand | -3.64 Million |
| Financing Cash Flow | -13.58 Million | 183.84 Million | -13.73 Million | 165.83 Million | - | 521.84 Thousand |
| Debt repayment | - | -49.92 Million | -3.96 Million | - | - | -19.5 Million |
| Dividends payments | -24.95 Million | -15.59 Million | -10.39 Million | -31.18 Million | - | -44.26 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 13.58 Million | 251.61 Million | -3.96 Million | 197.01 Million | - | 20.06 Million |
| Accounts receivables | -6.93 Million | -2.34 Million | -28.44 Million | 13.44 Million | 22.98 Million | 44.99 Million |
| Accounts payables | 29.69 Million | -18.36 Million | 53.92 Million | 59.08 Million | -35.63 Million | -43.73 Million |
| Inventory | -50.74 Million | 10.12 Million | -60.15 Million | -21.23 Million | -927.58 Thousand | -16.23 Million |
| Other working capital | -5.03 Million | -3.76 Million | 782.54 Thousand | 29.11 Thousand | -37.72 Thousand | 1.22 Million |
| Cash at beginning of period | 281.62 Million | 172.82 Million | 319.98 Million | 15.73 Million | 18.7 Million | 26.83 Million |
| Cash at end of period | 97.92 Million | 281.62 Million | 172.82 Million | 319.98 Million | 15.73 Million | 18.7 Million |
| Capital Expenditure | -176.24 Million | -29.14 Million | -25.91 Million | -7.07 Million | -22.37 Million | -42.29 Million |
| Effect of forex changes on cash | 301.01 Thousand | -63.4 Thousand | -20.63 Thousand | -174.83 Thousand | -137.78 Thousand | -39.53 Thousand |
| Net cash flow / Change in cash | -183.69 Million | 108.8 Million | -147.16 Million | 304.25 Million | -2.97 Million | -8.13 Million |
| Free Cash Flow | -174.3 Million | 60.24 Million | 10.05 Million | 99.21 Million | 6.66 Million | -4.96 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.73 Million | 708.96 Thousand | 5.87 Million | 18.44 Million | -1.64 Million | -1.88 Million |
| Depreciation & Amortization | - | 5.2 Million | 5.2 Million | 11.18 Million | 11.18 Million | -5.09 Million |
| Deferred income taxes | - | - | - | 6.3 Million | - | -1.46 Million |
| Stock-based compensation | - | - | - | -1.87 Million | -1.87 Million | -7.06 Million |
| Change in working capital | - | -20.32 Million | - | -21.68 Million | -62.71 Million | 13.62 Million |
| Other non-cash items | -10.26 Million | -4.38 Million | -12.16 Million | -2.47 Million | 67.6 Million | -1.14 Million |
| Investing Cash Flow | 52.08 Million | -24.04 Million | 386.29 Thousand | -172.34 Million | -149.98 Million | 68.67 Million |
| Investments in PPE | -4.13 Million | -3.05 Million | -8.6 Million | -176.24 Million | -152.52 Million | -2.1 Million |
| Acquisitions | - | - | - | 180.29 Thousand | 158.96 Thousand | -2.75 Million |
| Investment purchases | 374 Million | -378 Million | - | -4 Million | -394 Million | 110 Million |
| Sales/Maturities of investments | -366 Million | 366 Million | - | 397.71 Million | 397.71 Million | -40 Million |
| Other Investing Activities | 48.21 Million | -8.99 Million | 8.99 Million | 7.71 Million | 6.38 Million | 3.54 Million |
| Financing Cash Flow | 7.38 Million | -2.66 Million | 1.00 | -13.58 Million | -31.82 Million | 29.54 Million |
| Debt repayment | -7.39 Million | -8.25 Million | - | - | -30 Million | -30 Million |
| Dividends payments | - | -10.91 Million | - | -24.95 Million | -24.95 Million | -454.89 Thousand |
| Common Stock Repurchased | - | - | - | - | - | -19.11 Million |
| Common Stock Issuance | - | - | - | - | - | -10.88 Million |
| Other Financing Activities | -6877.09 | 8.25 Million | - | 13.58 Million | 23.12 Million | 90 Million |
| Accounts receivables | - | -21.67 Million | - | -6.93 Million | -6.93 Million | -4.01 Million |
| Accounts payables | - | - | - | 29.69 Million | - | - |
| Inventory | - | 1.35 Million | - | -50.74 Million | -50.74 Million | 21.55 Million |
| Other working capital | - | - | - | -5.03 Million | -5.03 Million | -3.91 Million |
| Cash at beginning of period | 300.03 Million | 381.29 Million | 97.92 Million | 281.62 Million | 265.05 Million | 169.17 Million |
| Cash at end of period | 171.22 Million | 300.03 Million | 92.03 Million | 97.92 Million | 97.92 Million | 265.05 Million |
| Capital Expenditure | -4.13 Million | -3.05 Million | -8.6 Million | -176.24 Million | -152.52 Million | -2.1 Million |
| Effect of forex changes on cash | - | 52.03 Thousand | 16.86 Thousand | 301.01 Thousand | 421.11 Thousand | 6703.78 |
| Net cash flow / Change in cash | -128.8 Million | -81.26 Million | -5.89 Million | -183.69 Million | -167.12 Million | 95.87 Million |
| Free Cash Flow | -9.67 Million | -11.93 Million | -14.9 Million | -174.3 Million | -138.08 Million | -5.12 Million |
002694
300142
PALREDTEC
SURE
ASHAPURMIN
GDHG